year 2, Issue 6 (6-2003)
J. Med. Plants 2003, 2(6): 33-40 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nazar Alipoor A, Sefidkon F. Quantitative and Qualitative Study of the Essential Oil from Aromatic and Medicinal Tripleurospermum disciforme (C.A.Mey.) Schultz- Bip. J. Med. Plants 2003; 2 (6) :33-40
URL: http://jmp.ir/article-1-779-en.html
URL: http://jmp.ir/article-1-779-en.html
1- Chemistry Group, Faculty of Science, Shahid Beheshti University, Tehran.
2- Phytochemistry Group, Department of Medicinal Plants, Research Institute of Forests and Rangelands ,frsef@yahoo.com
2- Phytochemistry Group, Department of Medicinal Plants, Research Institute of Forests and Rangelands ,
Abstract: (7672 Views)
In this study, the aerial parts of Tripleurospermum disiforme were collected in complete flowering stage from Taleghan in July 2001. After drying in shade, the plant material was subjected to steam distillation. The pale yellow oil was obtained at 0.45% (w/w) yield. The oil was analyzed by a combination of GC and GC/MS. Results of this investigation that was done the first time in Iran, were identification of 14 compounds (representing 94.93% of the oil) by percentage more than 0.07% in the oil. The main components of Tripleurospermum disiforme oil were trans, trans matricaria ester (39.93%), cis calamenene (22.99%), (Z)-b-farnesene (12.54%), b-maaliene (7.98%) and b-sesquiphellandrene (2.22%).
Keywords: Tripleurospermum disciforme, essential oil, trans matricaria ester, cis calamenene, (Z)-b-farnesene.
Type of Study: Research |
Subject:
Pharmacognosy & Pharmaceutics
Received: 2001/12/15 | Accepted: 2003/05/1 | Published: 2003/06/19
Received: 2001/12/15 | Accepted: 2003/05/1 | Published: 2003/06/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
